MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain
Go back to MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain| Miracle Applications Corp (NASDAQ: MIRA) | Delayed: 0.77 +0.02 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.75 | 52 Week High | $0.04 | |||
| Open | $0.75 | 52 Week Low | $0.00 | |||
| Day High | $0.78 | P/E | N/A | |||
| Day Low | $0.74 | EPS | $0.00 | |||
| Volume | 44,118 | |||||
